Illinois Administrative Code › Title 77 - PUBLIC HEALTH › Part 330 - SHELTERED CARE FACILITIES CODE › Subpart E - HEALTH SERVICES AND MEDICAL CARE OF RESIDENTS › Section 330.1155 - Unnecessary, Psychotropic, and Antipsychotic Drugs

Current through Register Vol. 48, No. 28, July 12, 2024
a) For the purposes of this Section the
				following definitions shall apply:
1) "Adverse
				consequence" - unwanted, uncomfortable, or dangerous effects that a medication
				may have, such as impairment or decline in an individual's mental or physical
				condition or functional or psychosocial status. It may include, but is not
				limited to, various types of adverse medication reactions and interactions
				(e.g., medication-medication, medication-food, and
				medication-disease).
2)
				"Antipsychotic medication" - a medication that is used to treat symptoms of
				psychosis such as delusions, hearing voices, hallucinations, paranoia, or
				confused thoughts. Antipsychotic medications are used in the treatment of
				schizophrenia, severe depression, and severe anxiety. Older antipsychotic
				medications tend to be called typical antipsychotics. Those developed more
				recently are called atypical antipsychotics.
3) "Dose" - the total
				amount/strength/concentration of a medication given at one time or over a
				period of time. The individual dose is the amount/strength/concentration
				received at each administration. The amount received over a 24-hour period may
				be referred to as the daily dose.
4) "Duplicative therapy" - multiple
				medications of the same pharmacological class or category or any medication
				therapy that substantially duplicates a particular effect of another medication
				that the individual is taking.
5)
				"Emergency" -
has the same meaning as in Section 1-112 of the
				Act
and Section
				330.330. (Section 2-106.1(b-3)
				of the Act)
6) "Excessive dose" -
				the total amount of any medication (including duplicative therapy) given at one
				time or over a period of time that is greater than the amount recommended by
				the manufacturer's label, package or insert, and the accepted standards of
				practice for a resident's age and condition.
7) "Gradual dose reduction" - the stepwise
				tapering of a dose to determine if symptoms, conditions, or risks can be
				managed by a lower dose or if the dose or medication can be
				discontinued.
8) "Informed consent"
				- documented, written permission for specific medications, given freely,
				without coercion or deceit, by a capable resident, or by a resident's surrogate
				decision maker, after the resident, or the resident's surrogate decision maker,
				has been fully informed of, and had an opportunity to consider, the nature of
				the medications, the likely benefits and most common risks to the resident of
				receiving the medications, any other likely and most common consequences of
				receiving or not receiving the medications, and possible alternatives to the
				proposed medications.
9) "Licensed
				nurse" -
an advanced practice registered nurse, a registered nurse, or
				a licensed nurse
, as defined in the Nurse Practice Act. (Section
				2-106.1(d) of the Act)
10)
				"
Psychotropic medication"
-
medication that is used
				for or listed as used for psychotropic, antidepressant, antimanic or
				antianxiety behavior modification or behavior management purposes in
				the
Prescribers Digital Reference database, the Lexicomp-online
				database, or the American Society of Health-System Pharmacists database.
				(Section 2-106.1(b-3) of the Act)
11)
"Surrogate decision maker" - an
				individual representing the resident's interests
in regard to consent
				to receive psychotropic medications,
as permitted by
Section
				2-106.1(b-3) of the Act and this Section. (Section
				2-106.1(b-3)